Selected research
Market Structure
Global Custom DNA Oligos Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Custom DNA Oligos market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Custom DNA Oligos is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Custom DNA Oligos is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Custom DNA Oligos is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Custom DNA Oligos is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Custom DNA Oligos include Wuhan GeneCreate Biological Engineering, General Biol, Atantares, Beyotime, Thermo Fisher Scientific, Merck, Genscript, Guangzhou RiboBio and Tsingke, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Custom DNA Oligos market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Custom DNA Oligos and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Custom DNA Oligos revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Custom DNA Oligos market size, projected growth trends, production technologies, key applications, and end-use industries.
Custom DNA Oligos Segment by Company
Wuhan GeneCreate Biological Engineering
General Biol
Atantares
Beyotime
Thermo Fisher Scientific
Merck
Genscript
Guangzhou RiboBio
Tsingke
Abace Biotechnology
TriLink BioTechnologies
Synbio Technologies
Macrogen
Integrated DNA Technologies (IDT)
Eurogentec
Cusabio
BBI Life Sciences
Azenta Life Sciences
Aurigene Pharmaceutical Services
Custom DNA Oligos Segment by Type
Common Primer Synthesis
Modified Primer Synthesis
Custom DNA Oligos Segment by Application
Biotech Company
Academic Scientific Research Institution
Custom DNA Oligos Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom DNA Oligos market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom DNA Oligos and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom DNA Oligos.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Custom DNA Oligos in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom DNA Oligos industry.
Chapter 3: Detailed analysis of Custom DNA Oligos companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom DNA Oligosrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Common Primer Synthesis
- Modified Primer Synthesis
Applications
- Biotech Company
- Academic Scientific Research Institution
Companies covered
- Wuhan GeneCreate Biological Engineering
- General Biol
- Atantares
- Beyotime
- Thermo Fisher Scientific
- Merck
- Genscript
- Guangzhou RiboBio
- Tsingke
- Abace Biotechnology
- TriLink BioTechnologies
- Synbio Technologies
- Macrogen
- Integrated DNA Technologies (IDT)
- Eurogentec
- Cusabio
- BBI Life Sciences
- Azenta Life Sciences
- Aurigene Pharmaceutical Services
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Custom DNA Oligos Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Common Primer Synthesis
- 1.2.3 Modified Primer Synthesis
- 1.3 Market Analysis by Application
- 1.3.1 Global Custom DNA Oligos Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Biotech Company
- 1.3.3 Academic Scientific Research Institution
- 1.4 Global Market Growth Prospects
- 1.5 Global Custom DNA Oligos Growth Trends by Region
- 1.5.1 Global Custom DNA Oligos Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Custom DNA Oligos Market Size by Region (2021-2026)
- 1.5.3 Custom DNA Oligos Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Custom DNA Oligos Market Dynamics
- 2.1 Custom DNA Oligos Industry Trends
- 2.2 Custom DNA Oligos Industry Drivers
- 2.3 Custom DNA Oligos Industry Opportunities and Challenges
- 2.4 Custom DNA Oligos Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Custom DNA Oligos Revenue by Company (2021-2026)
- 3.2 Global Custom DNA Oligos Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Custom DNA Oligos Key Company Head office and Area Served
- 3.4 Global Custom DNA Oligos Company, Product Type & Application
- 3.5 Global Custom DNA Oligos Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Custom DNA Oligos Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Custom DNA Oligos Players Market Share by Revenue in 2025
- 3.6.3 2025 Custom DNA Oligos Tier 1, Tier 2, and Tier 3
4 Custom DNA Oligos Market by Type
- 4.1 Global Custom DNA Oligos Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Custom DNA Oligos Market Size by Type (2021-2032)
- 4.3 Global Custom DNA Oligos Market Size Share by Type (2021-2032)
5 Custom DNA Oligos Market by Application
- 5.1 Global Custom DNA Oligos Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Custom DNA Oligos Market Size by Application (2021-2032)
- 5.3 Global Custom DNA Oligos Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Wuhan GeneCreate Biological Engineering
- 6.1.1 Wuhan GeneCreate Biological Engineering Company Information
- 6.1.2 Wuhan GeneCreate Biological Engineering Business Overview
- 6.1.3 Wuhan GeneCreate Biological Engineering Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Wuhan GeneCreate Biological Engineering Custom DNA Oligos Product Portfolio
- 6.1.5 Wuhan GeneCreate Biological Engineering Recent Developments
- 6.2 General Biol
- 6.2.1 General Biol Company Information
- 6.2.2 General Biol Business Overview
- 6.2.3 General Biol Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 General Biol Custom DNA Oligos Product Portfolio
- 6.2.5 General Biol Recent Developments
- 6.3 Atantares
- 6.3.1 Atantares Company Information
- 6.3.2 Atantares Business Overview
- 6.3.3 Atantares Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Atantares Custom DNA Oligos Product Portfolio
- 6.3.5 Atantares Recent Developments
- 6.4 Beyotime
- 6.4.1 Beyotime Company Information
- 6.4.2 Beyotime Business Overview
- 6.4.3 Beyotime Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Beyotime Custom DNA Oligos Product Portfolio
- 6.4.5 Beyotime Recent Developments
- 6.5 Thermo Fisher Scientific
- 6.5.1 Thermo Fisher Scientific Company Information
- 6.5.2 Thermo Fisher Scientific Business Overview
- 6.5.3 Thermo Fisher Scientific Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Thermo Fisher Scientific Custom DNA Oligos Product Portfolio
- 6.5.5 Thermo Fisher Scientific Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Merck Custom DNA Oligos Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Genscript
- 6.7.1 Genscript Company Information
- 6.7.2 Genscript Business Overview
- 6.7.3 Genscript Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Genscript Custom DNA Oligos Product Portfolio
- 6.7.5 Genscript Recent Developments
- 6.8 Guangzhou RiboBio
- 6.8.1 Guangzhou RiboBio Company Information
- 6.8.2 Guangzhou RiboBio Business Overview
- 6.8.3 Guangzhou RiboBio Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Guangzhou RiboBio Custom DNA Oligos Product Portfolio
- 6.8.5 Guangzhou RiboBio Recent Developments
- 6.9 Tsingke
- 6.9.1 Tsingke Company Information
- 6.9.2 Tsingke Business Overview
- 6.9.3 Tsingke Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Tsingke Custom DNA Oligos Product Portfolio
- 6.9.5 Tsingke Recent Developments
- 6.10 Abace Biotechnology
- 6.10.1 Abace Biotechnology Company Information
- 6.10.2 Abace Biotechnology Business Overview
- 6.10.3 Abace Biotechnology Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Abace Biotechnology Custom DNA Oligos Product Portfolio
- 6.10.5 Abace Biotechnology Recent Developments
- 6.11 TriLink BioTechnologies
- 6.11.1 TriLink BioTechnologies Company Information
- 6.11.2 TriLink BioTechnologies Business Overview
- 6.11.3 TriLink BioTechnologies Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 TriLink BioTechnologies Custom DNA Oligos Product Portfolio
- 6.11.5 TriLink BioTechnologies Recent Developments
- 6.12 Synbio Technologies
- 6.12.1 Synbio Technologies Company Information
- 6.12.2 Synbio Technologies Business Overview
- 6.12.3 Synbio Technologies Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Synbio Technologies Custom DNA Oligos Product Portfolio
- 6.12.5 Synbio Technologies Recent Developments
- 6.13 Macrogen
- 6.13.1 Macrogen Company Information
- 6.13.2 Macrogen Business Overview
- 6.13.3 Macrogen Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Macrogen Custom DNA Oligos Product Portfolio
- 6.13.5 Macrogen Recent Developments
- 6.14 Integrated DNA Technologies (IDT)
- 6.14.1 Integrated DNA Technologies (IDT) Company Information
- 6.14.2 Integrated DNA Technologies (IDT) Business Overview
- 6.14.3 Integrated DNA Technologies (IDT) Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Integrated DNA Technologies (IDT) Custom DNA Oligos Product Portfolio
- 6.14.5 Integrated DNA Technologies (IDT) Recent Developments
- 6.15 Eurogentec
- 6.15.1 Eurogentec Company Information
- 6.15.2 Eurogentec Business Overview
- 6.15.3 Eurogentec Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Eurogentec Custom DNA Oligos Product Portfolio
- 6.15.5 Eurogentec Recent Developments
- 6.16 Cusabio
- 6.16.1 Cusabio Company Information
- 6.16.2 Cusabio Business Overview
- 6.16.3 Cusabio Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Cusabio Custom DNA Oligos Product Portfolio
- 6.16.5 Cusabio Recent Developments
- 6.17 BBI Life Sciences
- 6.17.1 BBI Life Sciences Company Information
- 6.17.2 BBI Life Sciences Business Overview
- 6.17.3 BBI Life Sciences Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 BBI Life Sciences Custom DNA Oligos Product Portfolio
- 6.17.5 BBI Life Sciences Recent Developments
- 6.18 Azenta Life Sciences
- 6.18.1 Azenta Life Sciences Company Information
- 6.18.2 Azenta Life Sciences Business Overview
- 6.18.3 Azenta Life Sciences Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Azenta Life Sciences Custom DNA Oligos Product Portfolio
- 6.18.5 Azenta Life Sciences Recent Developments
- 6.19 Aurigene Pharmaceutical Services
- 6.19.1 Aurigene Pharmaceutical Services Company Information
- 6.19.2 Aurigene Pharmaceutical Services Business Overview
- 6.19.3 Aurigene Pharmaceutical Services Custom DNA Oligos Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Aurigene Pharmaceutical Services Custom DNA Oligos Product Portfolio
- 6.19.5 Aurigene Pharmaceutical Services Recent Developments
7 North America
- 7.1 North America Custom DNA Oligos Market Size (2021-2032)
- 7.2 North America Custom DNA Oligos Market Size by Type
- 7.2.1 North America Custom DNA Oligos Market Size by Type (2021-2026)
- 7.2.2 North America Custom DNA Oligos Market Size by Type (2027-2032)
- 7.2.3 North America Custom DNA Oligos Market Share by Type (2021-2032)
- 7.3 North America Custom DNA Oligos Market Size by Application
- 7.3.1 North America Custom DNA Oligos Market Size by Application (2021-2026)
- 7.3.2 North America Custom DNA Oligos Market Size by Application (2027-2032)
- 7.3.3 North America Custom DNA Oligos Market Share by Application (2021-2032)
- 7.4 North America Custom DNA Oligos Market Size by Country
- 7.4.1 North America Custom DNA Oligos Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Custom DNA Oligos Market Size by Country (2021-2026)
- 7.4.3 North America Custom DNA Oligos Market Size by Country (2027-2032)
- 7.4.4 North America Custom DNA Oligos Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Custom DNA Oligos Market Size (2021-2032)
- 8.2 Europe Custom DNA Oligos Market Size by Type
- 8.2.1 Europe Custom DNA Oligos Market Size by Type (2021-2026)
- 8.2.2 Europe Custom DNA Oligos Market Size by Type (2027-2032)
- 8.2.3 Europe Custom DNA Oligos Market Share by Type (2021-2032)
- 8.3 Europe Custom DNA Oligos Market Size by Application
- 8.3.1 Europe Custom DNA Oligos Market Size by Application (2021-2026)
- 8.3.2 Europe Custom DNA Oligos Market Size by Application (2027-2032)
- 8.3.3 Europe Custom DNA Oligos Market Share by Application (2021-2032)
- 8.4 Europe Custom DNA Oligos Market Size by Country
- 8.4.1 Europe Custom DNA Oligos Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Custom DNA Oligos Market Size by Country (2021-2026)
- 8.4.3 Europe Custom DNA Oligos Market Size by Country (2027-2032)
- 8.4.4 Europe Custom DNA Oligos Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Custom DNA Oligos Market Size (2021-2032)
- 9.2 China Custom DNA Oligos Market Size by Type
- 9.2.1 China Custom DNA Oligos Market Size by Type (2021-2026)
- 9.2.2 China Custom DNA Oligos Market Size by Type (2027-2032)
- 9.2.3 China Custom DNA Oligos Market Share by Type (2021-2032)
- 9.3 China Custom DNA Oligos Market Size by Application
- 9.3.1 China Custom DNA Oligos Market Size by Application (2021-2026)
- 9.3.2 China Custom DNA Oligos Market Size by Application (2027-2032)
- 9.3.3 China Custom DNA Oligos Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Custom DNA Oligos Market Size (2021-2032)
- 10.2 Asia Custom DNA Oligos Market Size by Type
- 10.2.1 Asia Custom DNA Oligos Market Size by Type (2021-2026)
- 10.2.2 Asia Custom DNA Oligos Market Size by Type (2027-2032)
- 10.2.3 Asia Custom DNA Oligos Market Share by Type (2021-2032)
- 10.3 Asia Custom DNA Oligos Market Size by Application
- 10.3.1 Asia Custom DNA Oligos Market Size by Application (2021-2026)
- 10.3.2 Asia Custom DNA Oligos Market Size by Application (2027-2032)
- 10.3.3 Asia Custom DNA Oligos Market Share by Application (2021-2032)
- 10.4 Asia Custom DNA Oligos Market Size by Country
- 10.4.1 Asia Custom DNA Oligos Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Custom DNA Oligos Market Size by Country (2021-2026)
- 10.4.3 Asia Custom DNA Oligos Market Size by Country (2027-2032)
- 10.4.4 Asia Custom DNA Oligos Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Custom DNA Oligos Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Custom DNA Oligos Market Size by Type
- 11.2.1 South America, Middle East & Africa Custom DNA Oligos Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Custom DNA Oligos Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Custom DNA Oligos Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Custom DNA Oligos Market Size by Application
- 11.3.1 South America, Middle East & Africa Custom DNA Oligos Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Custom DNA Oligos Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Custom DNA Oligos Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Custom DNA Oligos Market Size by Country
- 11.4.1 South America, Middle East & Africa Custom DNA Oligos Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Custom DNA Oligos Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Custom DNA Oligos Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Custom DNA Oligos Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst